𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Molecular prenatal diagnosis of ataxia telangiectasia heterozygosity by direct mutational assays

✍ Scribed by L. Chessa; M. Piane; S. Prudente; C. Carducci; M. C. Mazzilli; A. Pachtì; M. Negrini; M. G. Narducci; G. Russo; L. Frati


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
160 KB
Volume
19
Category
Article
ISSN
0197-3851

No coin nor oath required. For personal study only.

✦ Synopsis


Ataxia telangiectasia (AT) is a severe autosomal recessive disease, rare but not infrequent in Italy. Owing to the seriousness of the disease, prenatal diagnosis has been attempted in the past by means of cytogenetic, biochemical, radio-biological and indirect molecular analyses. We performed the first direct molecular prenatal diagnosis of AT on a chorionic villi sample from a 37-year-old woman at the 10th week of pregnancy. She had two previous children suffering AT and two induced abortions. At molecular analysis her affected children were compound heterozygotes for mutations 7792C<T in exon 55 (from the mother) and 8283delTC in exon 59 (from the father). The prenatal diagnosis was performed by two different operators in double-blind form. Mutation 7792C<T was studied by restriction enzyme analysis using TaqI. Mutation 8283delTC was screened by heteroduplex analysis. The fetus was heterozygous for the mutation 7792C<T (confirmed by sequencing). In order to verify the possible contamination by maternal DNA, polymorphic loci HLA-DRB1 and HLA-DQA1, together with microsatellite markers D6S259, D11S2000, D11S29, D11S1778 and D11S2179, were examined. All these loci were informative, showing that the fetus received only one allele from each parent. The heterozygosity for ATM mutation 7792C<T was confirmed by molecular studies after the birth of a healthy male baby.


📜 SIMILAR VOLUMES


Prenatal molecular diagnosis of Wiskott–
✍ S. Giliani; M. Fiorini; P. Mella; F. Candotti; R. F. Schumacher; G. S. Wengler; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB 👁 1 views

We have performed prenatal diagnosis for Wiskott-Aldrich syndrome (WAS) in two unrelated families by direct gene analysis. Using a combined non-radioactive analysis of single-strand conformational polymorphism (SSCP) and heteroduplex formation (HD), followed by automated sequencing, we studied DNA f

Prenatal diagnosis of Machado–Joseph dis
✍ Jorge Sequeiros; Patrícia Maciel; Filomena Taborda; Susana Lêdo; José Carlos Roc 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 1 views

MJD is the most frequent dominant ataxia and an incapacitating disorder. Onset is most frequently during the reproductive years, and genetic counselling is its only means of prevention. The causative mutation-an expansion of a (CAG) n on chromosome 14q32.1-can now be directly detected. We now report

Prenatal diagnosis of heterozygosity for
✍ R. J. Pomponio; J. Hymes; A. Pandya; B. Landa; P. Melone; R. Javaheri; R. Mardac 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

Biotinidase deficiency is characterized by neurological and cutaneous abnormalities that can be prevented or ameliorated by oral biotin therapy. A child with biotinidase deficiency went undiagnosed for a long period and has irreversible neurological deficits despite biotin treatment. This child is h

PRENATAL DIAGNOSIS OF GLYCOGEN STORAGE D
✍ LEE-JUN C. WONG 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB

Current laboratory diagnosis for glycogen storage disease type la (GSD la) is established by functional enzyme assay to demonstrate the deficiency of glucosed-phosphate phosphatase (G6Pase). This procedure requires liver biopsy and is impractical for routine prenatal diagnosis owing to the high morb

Prenatal diagnosis of X-linked hyper-IGM
✍ R. Jayoussi–Assalia; A. Etzioni; L.D. Notarangelo; R. Brill-Zamir; L. Kasinetz; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 2 views

We present the first report of prenatal diagnosis of X-linked hyper-IgM syndrome by PCR-mediated site directed mutagenesis (PSM) in a woman known to carry the Q220X mutation in the CD40L gene. Using the simple PSM assay, the Q220X mutation was identified by chorionic villous sampling (CVS) at 11 wee